Sea Buckthorn Aqueous Infusion Impact
Sbaii
1 other identifier
interventional
60
1 country
1
Brief Summary
- A total of 60 overweight women (BMI 25-29.9 kg/m²), aged 18-50years, will be enrolled and randomized equally into intervention and control groups. The intervention group will consume a 5 g freshly prepared seabuckthorn aqueous infusion daily for 12 weeks, while controls maintain usual habits without supplementation.
- The seabuckthorn aqueous infusion will be prepared by using 250mL of potable boiled water and then cooled to a lukewarm temperature (around 40-45°C). At this point, 5 g of seabuckthorn powder will be added, stirred thoroughly until fully dispersed, and consumed immediately. The infusion will be freshly prepared once daily and administered in the morning after breakfast. Measurements will be conducted using the InBody 270, a validated bioelectrical impedance analyzer employed in this study to obtain accurate assessments of body weight, body mass index (BMI), waist-hip ratio, and visceral fat levels. The device offers segmental analysis and visceral fat estimation through non-invasive, standardized procedures, ensuring consistency and reliability in longitudinal tracking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
January 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2026
CompletedJanuary 2, 2026
December 1, 2025
3 months
December 17, 2025
December 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Body weight
unit of measurement in kilograms will be measured by weight machine
12 weeks
Body mass index
body mass index will be measured using body mass index calculator
at the end of intervention (12 week)
Secondary Outcomes (2)
visceral fat
at the end of intervention period (12 week)
waist-hip ratio
at the end of intervention period ( 12 week)
Study Arms (2)
1
PLACEBO COMPARATORThe participants in the control group will consume placebo that will match in appearance to the supplement and is used to maintain blinding. Participants will consume freshly prepared sea buckthorn aqueous infusion daily for 12 weeks.
2
EXPERIMENTALDrug (Sea buckthorn aqueous infusion) The participants will consume Sea buckthorn aqueous infusion supplementation daily for 12 weeks. it will be prepared by using 5g sb powder in 250 ml of water.
Interventions
Sea buckthorn aqueous infusion prepared by using 5g powder in 250 ml water.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of veterinary and animal sciences, Lahore
Lahore, Punjab Province, 5400, Pakistan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
December 17, 2025
First Posted
January 2, 2026
Study Start
January 1, 2026
Primary Completion
March 30, 2026
Study Completion
April 15, 2026
Last Updated
January 2, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share